Pi3K Inhibitors Market to Reach $10.4 Billion by 2032 with 11.2% CAGR Driven by Oncology and Immunotherapy Advances
The global Pi3K Inhibitors Market is witnessing rapid growth due to increasing cancer prevalence and adoption of targeted therapies. In 2023, the market was valued at USD 4.8 billion, rising to USD 5.35 billion in 2024, representing a year-over-year growth of 11.5%. Expansion of immuno-oncology pipelines, growing incidence of hematologic and solid tumors, and regulatory approvals for novel...
0 Commentarii 0 Distribuiri 17 Views 0 previzualizare